About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Making Activity Time for Cognitive Health | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04255225

Making Activity Time for Cognitive Health

Approximately 75% of cancer survivors experience some degree of cognitive deficit throughout their cancer experience, with upwards of one third of breast cancer survivors reporting impairments up to a...

Lead sponsor: University of Illinois at Urbana-Champaign•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Illinois at Urbana-Champaign

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•women over the age of 18
•diagnosis of breast cancer
•no longer undergoing treatment
•fluent in English
•no history of dementia or organic brain syndrome
•not currently pregnant
•able to walk unassisted
•no health reasons that would prevent ability to exercise
•not currently enrolled in another exercise research study
•reported trouble with memory/concentration
•physician's consent

Exclusion Criteria

•male
•no diagnosis of breast cancer
•under 18 years of age
•currently undergoing treatment for breast cancer
•inability to communicate in English
•history of dementia or organic brain syndrome
•pregnant
•unable to walk unassisted
•other health reasons that may prevent ability to exercise
•enrolled in another exercise research study
•no reported trouble with memory or concentration
•non-consent of physician

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878 · Advanced Breast Cancer

RECRUITINGPhase 2

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998 · Breast Cancer

RECRUITINGPhase 2

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

RECRUITINGPhase 4

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateSep 2016

Last updatedFeb 11, 2020

Condition

Breast Cancer Cancer-related Problem/Condition Cognitive Impairment Physical Activity

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions